Skip to content

Pain control in patients with endometriosis through relaxation methods and activity exercises supported by "virtual reality" technology

Pain control in patients with endometriosis through relaxation methods and activity exercises supported by "virtual reality" technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030189
Enrollment
24
Registered
2022-09-22
Start date
2022-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N80

Interventions

Group 1: Each of the 24 patients will be assigned to a program (A, B, C) for 4 weeks, so that 8 patients each start with either HypnoVR relaxation module (A), the activity module SyncVR Fit (B), or th

Sponsors

Department für Frauengesundheit
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age over 18. - Severe pain reported in clinical routine (minimum of 5 points on NRS scale). - Willingness not to schedule surgery or start a new analgesic (non-opioid and opioid analgesics) during participation in the study (except for established emergency medication). - Willingness not to start a new non-drug treatment such as acupuncture, behavioral therapy, massage. If such therapy exists, it should be continued unchanged - Signed patient information and consent form - Understanding of the German language, ability to consent and compliance - The patient has understood the principle of the patient diary and agrees to keep it according to the instructions and to use the VR glasses according to the instructions.

Exclusion criteria

Exclusion criteria: - Start of regular use of opioid analgesics within 7 days prior to study entry. - Serious mental illness (e.g., psychosis, schizophrenia, bipolar disorder), major depression, screening using the questionnaires, DASS (determining the likelihood of the presence of a depressive disorder or anxiety disorder. - Epilepsy

Design outcomes

Primary

MeasureTime frame
The average pain intensity during the day and the maximum pain intensity during the day measured by the NRS scale from 0-10 Daily, throughout the entire study period (14 week of intervention): Daily record (the average pain intensity, max. pain intensity, on- demand medication), using the pain e-diary

Secondary

MeasureTime frame
1. Pain-related impairment as measured by the PDI score improves by 20% 2. Improvement in general health-related quality of life measured by the SF 12 3. Sleep quality improves as measured by the MOS-SS

Countries

Germany

Contacts

Public ContactJürgen Andress

Department für Frauengesundheit

juergen.andress@med.uni-tuebingen.de07071 29 82211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026